Table 3.
The effect of Fe3O4/Cs on PI3K/AKT/ mTOR and MAPK (P38, ERK1/2, and JNK) pathways
PI3K | AKT | mTOR | P38 | ERK1/2 | JNK | |
---|---|---|---|---|---|---|
Control | 1.02 ± 0.01 | 1.02 ± 0.01 | 1.00 ± 0.04 | 1.01 ± 0.01 | 1.04 ± 0.02 | 1.04 ± 0.04 |
Fe3O4/Cs | 1.03 ± 0.02 | 1.06 ± 0.03 | 1.00 ± 0.01 | 1.04 ± 0.03 | 1.01 ± 0.01 | 1.03 ± 0.01 |
DEN | 5.30 ± 0.85a | 2.95 ± 0.21a | 4.70 ± 0.21a | 5.13 ± 0.01a | 5.07 ± 0.05a | 3.65 ± 0.21a |
DEN + Fe3O4/Cs | 2.42 ± 0.54b | 1.27 ± 0.33 b | 2.20 ± 0.14a,b | 2.10 ± 0.42a,b | 3.55 ± 0.35a,b | 1.30 ± 0.14b |
Each value represents the mean ± standard deviation.
aSignificant difference versus control group at P ≤ 0.05.
bSignificant difference versus DEN group at P ≤ 0.05.